The RNA Therapeutic Modalities Summit is North America’s only industry led conference covering clinical progress and commercial scale development for the full spectrum of RNA therapeutic approaches.

Our agenda will featuring the pioneering biotechs translating current vaccine success into further clinically validated treatments in broader indications using RNA technologies such as antisense oligonucleotides, aptamers, small interfering RNAs (siRNAs), microRNAs, and messenger RNA (mRNA).

There will be dedicated discussion on the rationale for different mechanisms-of-action, how to optimise the power and versatility of RNA-based constructs, and the progress to date in disease indications encompassing neurodegeneration, metabolic and cardiovascular disorders and various cancers.

If your R&D teams are looking to establish a differentiated drug platform through RNA modification and delivery systems, improve stability, delivery and durability of current drug candidates, or enable tissue-specific administration with higher targeting ability and less toxicity, make sure they secure a place at this hotly anticipated conference. We look forward to welcoming you to Boston for dedicated in-person networking in June!

To know more visit: https://hubs.ly/Q012R75G0